United States · FDA National Drug Code directory
Mercaptopurine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71921-150_e7309808-5ae8-4a55-90e3-3992ace0da62
- Product NDC
- 71921-150
- Form
- TABLET
- Composition / generic term
- Mercaptopurine
- Labeler
- Florida Pharmaceutical Products, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20260130
- Source listing expiry
- 20271231
Source-listed ingredients
- MERCAPTOPURINE — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 25 TABLET in 1 BOTTLE (71921-150-02) · 71921-150-02
- 250 TABLET in 1 BOTTLE (71921-150-25) · 71921-150-25
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →